U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07412925) titled 'Impact Tourniquet Conservative Placenta Accreta Neonatal APGAR' on Nov. 21, 2025.
Brief Summary: Placenta accreta spectrum disorder (PAS) refers to a condition where the placenta fails to separate naturally after childbirth, which can cause significant maternal and neonatal complications, including severe bleeding, leading to increased morbidity and mortality. According to the pathological characteristics, PAS can be classified into three categories, including placenta accreta, placenta increta, and placenta percreta. Risk factors for PAS were identified as cesarean section (CS), hysteroscopy history, in vitro fertilization and embr...